National Health Scan
OTC:GEGR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
National Health Scan
Cash & Cash Equivalents
National Health Scan
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
National Health Scan
OTC:GEGR
|
Cash & Cash Equivalents
759.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Roper Technologies Inc
F:ROP
|
Cash & Cash Equivalents
$382.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-3%
|
|
|
General Electric Co
NYSE:GE
|
Cash & Cash Equivalents
$11B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-17%
|
|
|
3M Co
NYSE:MMM
|
Cash & Cash Equivalents
$3.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
11%
|
|
|
Honeywell International Inc
NASDAQ:HON
|
Cash & Cash Equivalents
$12B
|
CAGR 3-Years
20%
|
CAGR 5-Years
0%
|
CAGR 10-Years
10%
|
|
|
B
|
Brookfield Business Corp
TSX:BBUC
|
Cash & Cash Equivalents
$710m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
National Health Scan
Glance View
The company is headquartered in Henderson, Nevada. The company went IPO on 2001-06-21.
See Also
What is National Health Scan's Cash & Cash Equivalents?
Cash & Cash Equivalents
759.1m
Based on the financial report for Dec 31, 2011, National Health Scan's Cash & Cash Equivalents amounts to 759.1m .
What is National Health Scan's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
18%
Over the last year, the Cash & Cash Equivalents growth was -4%. The average annual Cash & Cash Equivalents growth rates for National Health Scan have been 18% over the past three years .